Grants per year
Personal profile
Research Interests
Colon cancer, Gastric cancer, Pancreas cancer, Rectal cancer
Certifications and Licenses
| Internal Medicine | |
| Medical Oncology |
Training Experience
| 1979 | Residency, Univ. of Wisconsin Hospital |
| 1984 | Fellowship, Univ. of Wisconsin Hospital |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MD, SUNY Buffalo
… → 1976
Research interests keywords
- Anal Cancer
- Colon/Rectal Cancer
- Esophageal Cancer
- GI Stromal Tumors
- Gastrointestinal Malignancies
- Liver Cancer
- Neuroendocrine Tumors
- Pancreatic Cancer
- Stomach Cancer
Fingerprint
Dive into the research topics where Al B Benson III is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #219606: A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Benson III, A. B. (PD/PI)
PPD Investigator Services, LLC, GlaxoSmithKline LLC
6/18/24 → 6/18/27
Project: Research project
-
Prot #1438-0007: DAREON™-7: A Phase I, Open-Label, Dose Escalation and Expansion Trial to Investigate Safety and Tolerability of BI 764532 Intravenous Infusions in Combination with Standard of Care (Platinum and Etoposide) in First-Line Treatment of Patie
Benson III, A. B. (PD/PI)
Boehringer Ingelheim Pharmaceuticals, Inc.
3/16/24 → 3/16/27
Project: Research project
-
Prot #M24-311: A Phase 2, Randomized Study to Evaluate Safety, Efficacy, and Optimal Dose of ABBV-400 in Combination with Fluorouracil, Folinic Acid, and Bevacizumab in Previously Treated Subjects with Unresectable Metastatic Colorectal Cancer
Benson III, A. B. (PD/PI)
2/14/24 → 2/14/27
Project: Research project
-
Prot #CRDF-003: A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS or NRAS Mutation
Benson III, A. B. (PD/PI)
1/31/24 → 1/30/25
Project: Research project
-
Prot #BTCRC GI15-067: A Phase II Study to Evaluate the Efficacy of Liposomal Irinotecan in Combination with Oxaliplatin, Leucovorin, and 5-Fluorouracil for Patients with Locally Advanced Pancreatic Carcinoma
Benson III, A. B. (PD/PI)
Hoosier Cancer Research Network, Inc., Ipsen Biopharmaceuticals, Inc.
12/8/20 → 12/8/25
Project: Research project
-
An update on pharmacotherapies for colorectal cancer: 2023 and beyond
Zhu, M. & Benson, A. B., 2024, In: Expert Opinion on Pharmacotherapy. 25, 1, p. 91-99 9 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Iams, W. T., Mackay, M., Ben-Shachar, R., Drews, J., Manghnani, K., Hockenberry, A. J., Cristofanilli, M., Nimeiri, H. S., Guinney, J. & Benson, A. B., 2024, (Accepted/In press) In: JAMA network open. p. E2351700Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations -
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program
Braun-Inglis, C. M., Dressler, E. V., Myers, J. S., Benson, A. B., Flannery, M., Good, M., Denicoff, A., Berenberg, J. L., DeTroye, A. T., Brien, B. O., Kottschade, L., Ann Omatsu, D., Kittel, C. A., Nightingale, C. L., Foust, M. & Lesser, G. J., Feb 1 2024, In: JCO Oncology Practice. 20, 2, p. 239-246 8 p.Research output: Contribution to journal › Article › peer-review
-
Ampullary Adenocarcinoma, Version 1.2023
Chiorean, E. G., Chiaro, M. D., Tempero, M. A., Malafa, M. P., Benson, A. B., Cardin, D. B., Christensen, J. A., Chung, V., Czito, B., Dillhoff, M., Donahue, T. R., Dotan, E., Fountzilas, C., Glazer, E. S., Hardacre, J., Hawkins, W. G., Klute, K., Ko, A. H., Kunstman, J. W. & LoConte, N. & 19 others, , Jul 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 7, p. 753-782 30 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Anal Carcinoma, Version 2.2023
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y. J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., Grem, J. L., Randolph Hecht, J., Hoffe, S., Hubbard, J., Hunt, S., Hussan, H., Jeck, W., Johung, K. L., Joseph, N. & Kirilcuk, N. & 23 others, , Jun 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 6, p. 653-677 25 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations
Datasets
-
Supplementary Material for: Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
Kelley, R. K. (Contributor), Joseph, N. M. (Contributor), Nimeiri, H. S. (Contributor), Hwang, J. (Contributor), Kulik, L. M. (Contributor), Ngo, Z. (Contributor), Behr, S. C. (Contributor), Onodera, C. (Contributor), Zhang, K. (Contributor), Bocobo, A. G. (Contributor), Benson, A. B. (Contributor), Venook, A. P. (Contributor) & Gordan, J. D. (Contributor), Karger Publishers, 2021
DOI: 10.6084/m9.figshare.16573370.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Phase_II_Trial_of_the_Combination_of_Temsirolimus_and_Sorafenib_in_Advanced_Hepatocellular_Carcinoma_with_Tumor_Mutation_Profiling/16573370/1
Dataset